Regulus Therapeutics Inc. Gains 54.83%

Wed, May 11, 2022 at 05:30 PM
Regulus Therapeutics Inc. Gains 54.83%

Regulus Therapeutics Inc. (RGLS:NASDAQ) jumped higher at $0.27, a gain of 54.8%. The stock appeared on our News Catalysts scanner on Wed, May 11, 2022 at 09:56 AM in the 'BIOTECH' category. From Tue, Apr 26, 2022, the stock recorded 10.00% Up Days and 9.09% Green Days

The stock spiked on Mon, Apr 04, 2022 at $0.37 with a volume of 2M+.

About Regulus Therapeutics Inc. (RGLS:NASDAQ)

Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.